In addition, other studies showed that IgA response in saliva mostly falls to baseline after 6 months post-infection and that vaccination can reactivate the mucosal response, suggesting that vaccine platforms inducing better mucosal immunity would be needed to control COVID-19 infections in the future [29]. Here, CD79A is linked to infection.